| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pan troglodytes | 9 | 2016 | 220 | 1.290 |
Why?
|
| Plague | 9 | 2016 | 16 | 0.870 |
Why?
|
| Yersinia pestis | 8 | 2016 | 11 | 0.740 |
Why?
|
| Ape Diseases | 2 | 2016 | 14 | 0.560 |
Why?
|
| Virulence Factors | 6 | 2016 | 233 | 0.550 |
Why?
|
| Lipoproteins | 6 | 2016 | 232 | 0.520 |
Why?
|
| Anthrax | 5 | 2024 | 37 | 0.500 |
Why?
|
| Rodent Diseases | 2 | 2006 | 31 | 0.480 |
Why?
|
| Macaca mulatta | 11 | 2017 | 731 | 0.480 |
Why?
|
| Bacillus anthracis | 4 | 2024 | 45 | 0.470 |
Why?
|
| Arteries | 1 | 2015 | 294 | 0.460 |
Why?
|
| Neocortex | 5 | 2013 | 98 | 0.430 |
Why?
|
| Hydronephrosis | 1 | 2012 | 51 | 0.420 |
Why?
|
| Leiomyoma | 1 | 2012 | 160 | 0.380 |
Why?
|
| Genital Diseases, Male | 2 | 2016 | 30 | 0.330 |
Why?
|
| Enterotoxins | 4 | 2014 | 122 | 0.330 |
Why?
|
| Animals | 62 | 2024 | 62827 | 0.320 |
Why?
|
| Saimiri | 2 | 2020 | 120 | 0.320 |
Why?
|
| Monkey Diseases | 2 | 2013 | 60 | 0.310 |
Why?
|
| Nephrectomy | 1 | 2012 | 808 | 0.300 |
Why?
|
| Bacterial Toxins | 4 | 2011 | 229 | 0.290 |
Why?
|
| Mice, Inbred ICR | 2 | 2006 | 246 | 0.290 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2006 | 17 | 0.280 |
Why?
|
| Plague Vaccine | 2 | 2016 | 2 | 0.270 |
Why?
|
| Kidney Tubules | 1 | 2006 | 146 | 0.270 |
Why?
|
| Lung | 10 | 2020 | 3295 | 0.260 |
Why?
|
| Antibodies, Bacterial | 6 | 2016 | 420 | 0.250 |
Why?
|
| Peptidomimetics | 2 | 2017 | 29 | 0.250 |
Why?
|
| Brain | 6 | 2016 | 4260 | 0.240 |
Why?
|
| Campylobacter Infections | 2 | 2002 | 42 | 0.230 |
Why?
|
| Aminoglycosides | 1 | 2024 | 235 | 0.220 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2002 | 432 | 0.210 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2017 | 503 | 0.210 |
Why?
|
| Campylobacter fetus | 1 | 2002 | 5 | 0.210 |
Why?
|
| Aeromonas hydrophila | 2 | 2014 | 5 | 0.210 |
Why?
|
| Bulbourethral Glands | 1 | 2002 | 8 | 0.200 |
Why?
|
| Plasminogen Activators | 2 | 2014 | 55 | 0.200 |
Why?
|
| Fetal Death | 1 | 2002 | 134 | 0.200 |
Why?
|
| Disease Models, Animal | 19 | 2024 | 7476 | 0.200 |
Why?
|
| Pyramidal Cells | 2 | 2013 | 171 | 0.200 |
Why?
|
| Edema | 3 | 2002 | 265 | 0.190 |
Why?
|
| Antigens, Bacterial | 4 | 2016 | 374 | 0.190 |
Why?
|
| Perineum | 1 | 2002 | 116 | 0.190 |
Why?
|
| Dendrites | 2 | 2013 | 206 | 0.190 |
Why?
|
| Cell Nucleus | 1 | 2006 | 1740 | 0.190 |
Why?
|
| Kidney Diseases | 1 | 2006 | 732 | 0.180 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 1073 | 0.180 |
Why?
|
| Metalloporphyrins | 1 | 2020 | 31 | 0.180 |
Why?
|
| Cysts | 1 | 2002 | 208 | 0.180 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2016 | 135 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 5603 | 0.170 |
Why?
|
| Respiratory Tract Infections | 1 | 2024 | 408 | 0.170 |
Why?
|
| Bacteriophages | 1 | 2020 | 83 | 0.170 |
Why?
|
| Adenoviridae Infections | 1 | 2020 | 114 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 4890 | 0.170 |
Why?
|
| Aerosols | 4 | 2008 | 149 | 0.160 |
Why?
|
| Fetus | 1 | 2002 | 674 | 0.160 |
Why?
|
| Mice | 24 | 2020 | 36056 | 0.160 |
Why?
|
| Female | 40 | 2024 | 149288 | 0.150 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 367 | 0.150 |
Why?
|
| Primate Diseases | 1 | 2018 | 21 | 0.150 |
Why?
|
| Phylogeny | 3 | 2020 | 870 | 0.150 |
Why?
|
| Aotidae | 1 | 2018 | 29 | 0.150 |
Why?
|
| Soman | 2 | 1997 | 6 | 0.150 |
Why?
|
| Pathology | 1 | 2018 | 108 | 0.150 |
Why?
|
| Leukemia L1210 | 1 | 2017 | 57 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 7976 | 0.140 |
Why?
|
| Staphylococcal Toxoid | 1 | 1996 | 1 | 0.140 |
Why?
|
| Analgesics, Opioid | 2 | 2004 | 1459 | 0.140 |
Why?
|
| Salmonella Vaccines | 1 | 2016 | 8 | 0.140 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2016 | 109 | 0.140 |
Why?
|
| Superantigens | 1 | 1996 | 32 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 129 | 0.140 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 73 | 0.140 |
Why?
|
| Salmonella Infections | 1 | 2016 | 44 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2016 | 718 | 0.140 |
Why?
|
| Animal Diseases | 1 | 2016 | 10 | 0.140 |
Why?
|
| Bacterial Vaccines | 1 | 1996 | 118 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2016 | 61 | 0.140 |
Why?
|
| Acetyltransferases | 1 | 2016 | 148 | 0.130 |
Why?
|
| Bacterial Proteins | 3 | 2015 | 1094 | 0.130 |
Why?
|
| Zika Virus | 1 | 2018 | 149 | 0.130 |
Why?
|
| Heat-Shock Proteins | 1 | 2017 | 339 | 0.130 |
Why?
|
| Receptor, EphA2 | 1 | 2017 | 139 | 0.130 |
Why?
|
| Adenoviruses, Human | 1 | 2016 | 191 | 0.130 |
Why?
|
| Zika Virus Infection | 1 | 2018 | 173 | 0.130 |
Why?
|
| Genital Diseases, Female | 1 | 2016 | 61 | 0.130 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2015 | 14 | 0.130 |
Why?
|
| Staphylococcus aureus | 2 | 1996 | 563 | 0.130 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 1995 | 48 | 0.120 |
Why?
|
| Spleen | 5 | 2010 | 732 | 0.120 |
Why?
|
| Acyltransferases | 1 | 2015 | 67 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2016 | 337 | 0.120 |
Why?
|
| Adenoviridae | 1 | 2020 | 1514 | 0.120 |
Why?
|
| Liposomes | 1 | 2017 | 711 | 0.120 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2015 | 132 | 0.120 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2014 | 33 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 3176 | 0.120 |
Why?
|
| Intestine, Small | 2 | 1997 | 527 | 0.110 |
Why?
|
| Genes, Bacterial | 1 | 2014 | 271 | 0.110 |
Why?
|
| Paresis | 1 | 2013 | 55 | 0.110 |
Why?
|
| Motor Cortex | 2 | 2012 | 127 | 0.100 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 2012 | 17 | 0.100 |
Why?
|
| RNA Interference | 1 | 2017 | 1397 | 0.100 |
Why?
|
| Myelin Proteins | 1 | 2012 | 93 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2017 | 586 | 0.100 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2013 | 159 | 0.100 |
Why?
|
| Injections, Spinal | 4 | 2004 | 275 | 0.100 |
Why?
|
| Rabbits | 5 | 2024 | 1077 | 0.100 |
Why?
|
| Injections, Intramuscular | 3 | 2016 | 249 | 0.100 |
Why?
|
| Macaca fascicularis | 3 | 2017 | 151 | 0.100 |
Why?
|
| Cytokines | 8 | 2016 | 2841 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2016 | 735 | 0.100 |
Why?
|
| Deoxycytidine | 1 | 2017 | 1378 | 0.100 |
Why?
|
| Myelin Sheath | 1 | 2012 | 170 | 0.100 |
Why?
|
| Plasmids | 2 | 2014 | 953 | 0.100 |
Why?
|
| Midazolam | 2 | 2004 | 72 | 0.090 |
Why?
|
| Research Design | 1 | 2018 | 1581 | 0.090 |
Why?
|
| Bone Marrow Diseases | 1 | 2012 | 187 | 0.090 |
Why?
|
| Biological Evolution | 1 | 2012 | 293 | 0.090 |
Why?
|
| Adipose Tissue, White | 1 | 2011 | 102 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 2219 | 0.090 |
Why?
|
| Hepatitis Viruses | 1 | 1990 | 6 | 0.090 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 14653 | 0.090 |
Why?
|
| Ependymoma | 1 | 2013 | 269 | 0.090 |
Why?
|
| ADP Ribose Transferases | 1 | 2010 | 28 | 0.090 |
Why?
|
| Synaptophysin | 1 | 2010 | 83 | 0.090 |
Why?
|
| A549 Cells | 2 | 2020 | 128 | 0.090 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2015 | 469 | 0.090 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1990 | 68 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 1 | 2010 | 132 | 0.090 |
Why?
|
| Sheep | 3 | 2004 | 273 | 0.080 |
Why?
|
| Peptides | 1 | 2015 | 1529 | 0.080 |
Why?
|
| Lymphoma | 1 | 2017 | 1514 | 0.080 |
Why?
|
| Dengue Virus | 2 | 1987 | 129 | 0.080 |
Why?
|
| Functional Laterality | 1 | 2010 | 288 | 0.080 |
Why?
|
| Male | 27 | 2020 | 129089 | 0.080 |
Why?
|
| Synapses | 1 | 2013 | 556 | 0.080 |
Why?
|
| Leukemia | 1 | 2017 | 1721 | 0.080 |
Why?
|
| Primates | 2 | 2020 | 134 | 0.080 |
Why?
|
| Gene Deletion | 4 | 2015 | 1487 | 0.080 |
Why?
|
| Proteins | 1 | 2016 | 2058 | 0.080 |
Why?
|
| Levofloxacin | 2 | 2024 | 56 | 0.080 |
Why?
|
| Heart Rate | 1 | 2011 | 761 | 0.080 |
Why?
|
| Liver | 4 | 2010 | 3124 | 0.080 |
Why?
|
| Aging | 1 | 2016 | 1578 | 0.070 |
Why?
|
| Vaccination | 3 | 2020 | 1156 | 0.070 |
Why?
|
| Lethal Dose 50 | 4 | 2009 | 38 | 0.070 |
Why?
|
| Weight Loss | 1 | 2011 | 639 | 0.070 |
Why?
|
| Infusion Pumps, Implantable | 2 | 2004 | 65 | 0.070 |
Why?
|
| Spinal Cord | 6 | 2013 | 724 | 0.070 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 1987 | 26 | 0.070 |
Why?
|
| Sentinel Surveillance | 1 | 2006 | 36 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2020 | 947 | 0.070 |
Why?
|
| Immunization Schedule | 2 | 2016 | 115 | 0.070 |
Why?
|
| Serologic Tests | 1 | 2006 | 150 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2009 | 915 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2011 | 748 | 0.070 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 967 | 0.070 |
Why?
|
| Vaccines, Attenuated | 2 | 2016 | 190 | 0.070 |
Why?
|
| Immunoglobulin A | 2 | 2016 | 274 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 3512 | 0.060 |
Why?
|
| Dactinomycin | 2 | 1997 | 163 | 0.060 |
Why?
|
| Virulence | 3 | 2014 | 352 | 0.060 |
Why?
|
| Myocardium | 1 | 2011 | 1252 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2011 | 1603 | 0.060 |
Why?
|
| Spores, Bacterial | 3 | 2011 | 46 | 0.060 |
Why?
|
| Survival Analysis | 5 | 2016 | 9326 | 0.060 |
Why?
|
| Tachyphylaxis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Feces | 2 | 2020 | 866 | 0.060 |
Why?
|
| Infusion Pumps | 1 | 2004 | 60 | 0.060 |
Why?
|
| Hydromorphone | 1 | 2004 | 61 | 0.060 |
Why?
|
| Humans | 26 | 2020 | 272091 | 0.060 |
Why?
|
| Cell Line | 3 | 2020 | 5433 | 0.050 |
Why?
|
| Granuloma | 1 | 2004 | 159 | 0.050 |
Why?
|
| Interferon-gamma | 3 | 2016 | 1180 | 0.050 |
Why?
|
| Neurons | 1 | 2013 | 2462 | 0.050 |
Why?
|
| Maximum Tolerated Dose | 2 | 2017 | 1323 | 0.050 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 1140 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2669 | 0.050 |
Why?
|
| SAIDS Vaccines | 1 | 2001 | 23 | 0.050 |
Why?
|
| Macrophages | 3 | 2015 | 1378 | 0.050 |
Why?
|
| Catheterization | 1 | 2004 | 425 | 0.050 |
Why?
|
| Colony Count, Microbial | 2 | 2014 | 161 | 0.050 |
Why?
|
| AIDS Vaccines | 1 | 2001 | 66 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 4371 | 0.050 |
Why?
|
| Morphine | 1 | 2003 | 332 | 0.050 |
Why?
|
| Heart | 1 | 2007 | 1214 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 570 | 0.050 |
Why?
|
| Chromatin | 1 | 2006 | 1050 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2014 | 172 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2020 | 43 | 0.050 |
Why?
|
| Genome, Bacterial | 1 | 2020 | 211 | 0.040 |
Why?
|
| Interferon Inducers | 1 | 1979 | 9 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2020 | 354 | 0.040 |
Why?
|
| Anticarcinogenic Agents | 1 | 2001 | 372 | 0.040 |
Why?
|
| Vaccines, Synthetic | 2 | 2016 | 371 | 0.040 |
Why?
|
| Mice, Inbred C3H | 2 | 1997 | 407 | 0.040 |
Why?
|
| Poly I-C | 1 | 1979 | 31 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2015 | 1718 | 0.040 |
Why?
|
| Obesity | 1 | 2011 | 2958 | 0.040 |
Why?
|
| Virus Replication | 2 | 2016 | 773 | 0.040 |
Why?
|
| Prodrugs | 1 | 2020 | 226 | 0.040 |
Why?
|
| Radiation-Protective Agents | 1 | 1979 | 129 | 0.040 |
Why?
|
| Placenta | 1 | 2002 | 566 | 0.040 |
Why?
|
| Immunity, Cellular | 2 | 2015 | 442 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 1057 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 1990 | 735 | 0.040 |
Why?
|
| Chemical Warfare Agents | 1 | 1997 | 9 | 0.040 |
Why?
|
| GABA Modulators | 1 | 1997 | 16 | 0.040 |
Why?
|
| Convulsants | 1 | 1997 | 32 | 0.040 |
Why?
|
| Dinoprostone | 2 | 2016 | 222 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2017 | 119 | 0.040 |
Why?
|
| HIV-1 | 1 | 2001 | 641 | 0.040 |
Why?
|
| Mutation | 2 | 2015 | 15944 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2017 | 73 | 0.040 |
Why?
|
| Phospholipases A2 | 1 | 2016 | 45 | 0.040 |
Why?
|
| Viremia | 1 | 2018 | 182 | 0.040 |
Why?
|
| Malaria | 2 | 1988 | 92 | 0.040 |
Why?
|
| Rats | 3 | 2017 | 6640 | 0.040 |
Why?
|
| Muscarinic Antagonists | 1 | 1997 | 82 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 5107 | 0.030 |
Why?
|
| Consanguinity | 1 | 2016 | 116 | 0.030 |
Why?
|
| Immunization, Secondary | 1 | 1996 | 116 | 0.030 |
Why?
|
| Cholinesterase Inhibitors | 1 | 1997 | 115 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 330 | 0.030 |
Why?
|
| Genitalia | 1 | 2016 | 47 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 181 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1996 | 269 | 0.030 |
Why?
|
| Viral Load | 1 | 2018 | 482 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 348 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 5187 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 3646 | 0.030 |
Why?
|
| Hemolysin Proteins | 1 | 1995 | 35 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 546 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2015 | 33909 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 88 | 0.030 |
Why?
|
| Bronchi | 1 | 1996 | 330 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2015 | 78 | 0.030 |
Why?
|
| Trachea | 1 | 1996 | 290 | 0.030 |
Why?
|
| Gentamicins | 1 | 2015 | 113 | 0.030 |
Why?
|
| Fresh Water | 1 | 2014 | 21 | 0.030 |
Why?
|
| Water Microbiology | 1 | 2014 | 29 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 3543 | 0.030 |
Why?
|
| Kidney | 2 | 2015 | 2267 | 0.030 |
Why?
|
| Proteinuria | 1 | 2015 | 166 | 0.030 |
Why?
|
| Pregnancy | 2 | 2002 | 8105 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2015 | 152 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 4496 | 0.030 |
Why?
|
| Immunization | 1 | 2015 | 402 | 0.030 |
Why?
|
| Time Factors | 4 | 2012 | 13139 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 1997 | 472 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2016 | 764 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 758 | 0.030 |
Why?
|
| Feedback, Sensory | 1 | 2013 | 21 | 0.030 |
Why?
|
| Papio | 1 | 1993 | 77 | 0.030 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2012 | 18 | 0.030 |
Why?
|
| Chemokines | 1 | 2014 | 296 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 205 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 1622 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2020 | 4360 | 0.030 |
Why?
|
| Biofilms | 1 | 2014 | 203 | 0.030 |
Why?
|
| Somatosensory Cortex | 1 | 2012 | 73 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2020 | 2139 | 0.030 |
Why?
|
| Skin | 2 | 2016 | 1284 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 6783 | 0.030 |
Why?
|
| Cercopithecidae | 1 | 2011 | 12 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2014 | 883 | 0.030 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2011 | 8 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 14881 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2014 | 605 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1756 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2015 | 424 | 0.020 |
Why?
|
| United States | 2 | 2020 | 16066 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 4200 | 0.020 |
Why?
|
| Telemetry | 1 | 2011 | 41 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 7828 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 3074 | 0.020 |
Why?
|
| Seizures | 1 | 1997 | 1051 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3929 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 203 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 4635 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 237 | 0.020 |
Why?
|
| Visual Cortex | 1 | 2012 | 131 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2011 | 5788 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2012 | 215 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 835 | 0.020 |
Why?
|
| Anthropometry | 1 | 2011 | 264 | 0.020 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1990 | 14 | 0.020 |
Why?
|
| Thromboxane B2 | 2 | 1987 | 27 | 0.020 |
Why?
|
| Campylobacter | 1 | 1990 | 29 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2010 | 148 | 0.020 |
Why?
|
| Troponin I | 1 | 2011 | 131 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 1670 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2013 | 8612 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 1569 | 0.020 |
Why?
|
| Buffaloes | 1 | 1989 | 4 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 2337 | 0.020 |
Why?
|
| Child | 4 | 2016 | 30559 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 1095 | 0.020 |
Why?
|
| Hand | 1 | 2010 | 176 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1990 | 362 | 0.020 |
Why?
|
| Infant | 3 | 2013 | 13970 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 4640 | 0.020 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2008 | 5 | 0.020 |
Why?
|
| Blood | 1 | 2008 | 172 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2016 | 3947 | 0.020 |
Why?
|
| Ofloxacin | 1 | 2008 | 43 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2008 | 2470 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2007 | 98 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 3671 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2400 | 0.020 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1987 | 40 | 0.020 |
Why?
|
| Vacuoles | 1 | 1987 | 46 | 0.020 |
Why?
|
| Encephalitis, Japanese | 1 | 1987 | 21 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 1989 | 405 | 0.020 |
Why?
|
| Virus Cultivation | 1 | 1987 | 80 | 0.020 |
Why?
|
| Computers | 1 | 1977 | 141 | 0.020 |
Why?
|
| Culicidae | 1 | 1987 | 68 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1987 | 160 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 2576 | 0.020 |
Why?
|
| Exocytosis | 1 | 1987 | 118 | 0.020 |
Why?
|
| Capsid | 1 | 1987 | 178 | 0.020 |
Why?
|
| Goats | 3 | 1981 | 70 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2007 | 299 | 0.020 |
Why?
|
| Aedes | 1 | 1987 | 99 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1987 | 239 | 0.020 |
Why?
|
| Motor Activity | 1 | 2010 | 718 | 0.020 |
Why?
|
| Virion | 1 | 1987 | 186 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5421 | 0.020 |
Why?
|
| Laboratories | 1 | 1977 | 139 | 0.020 |
Why?
|
| Hematology | 1 | 1977 | 99 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2011 | 824 | 0.020 |
Why?
|
| Morphogenesis | 1 | 1987 | 336 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2001 | 4797 | 0.020 |
Why?
|
| Wounds and Injuries | 2 | 1980 | 442 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 5115 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 1241 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 1987 | 520 | 0.020 |
Why?
|
| Movement Disorders | 1 | 1987 | 236 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1987 | 719 | 0.010 |
Why?
|
| Regional Blood Flow | 2 | 1987 | 285 | 0.010 |
Why?
|
| Ischemia | 1 | 1987 | 408 | 0.010 |
Why?
|
| Adolescent | 2 | 2016 | 32730 | 0.010 |
Why?
|
| Blood Cell Count | 2 | 1979 | 234 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 7302 | 0.010 |
Why?
|
| Burns | 2 | 1981 | 126 | 0.010 |
Why?
|
| Cisterna Magna | 1 | 2003 | 6 | 0.010 |
Why?
|
| Lameness, Animal | 1 | 2003 | 4 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1990 | 1296 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2003 | 38 | 0.010 |
Why?
|
| Biotransformation | 1 | 2003 | 98 | 0.010 |
Why?
|
| Spinal Cord Injuries | 1 | 1987 | 352 | 0.010 |
Why?
|
| Hindlimb | 1 | 2003 | 112 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1987 | 900 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1988 | 1497 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2004 | 250 | 0.010 |
Why?
|
| Mestranol | 1 | 2001 | 4 | 0.010 |
Why?
|
| Norethindrone | 1 | 2001 | 16 | 0.010 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2001 | 19 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2001 | 95 | 0.010 |
Why?
|
| Fenretinide | 1 | 2001 | 100 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2001 | 296 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 3651 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2001 | 207 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 675 | 0.010 |
Why?
|
| Adult | 3 | 2012 | 81933 | 0.010 |
Why?
|
| Viral Envelope Proteins | 1 | 2001 | 219 | 0.010 |
Why?
|
| Thailand | 2 | 1990 | 37 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 1610 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2013 | 17056 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2001 | 637 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2001 | 370 | 0.010 |
Why?
|
| Cobalt Radioisotopes | 1 | 1979 | 41 | 0.010 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 1979 | 20 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1979 | 33 | 0.010 |
Why?
|
| Colony-Stimulating Factors | 1 | 1979 | 83 | 0.010 |
Why?
|
| Plasmodium berghei | 2 | 1988 | 14 | 0.010 |
Why?
|
| Oxygen Consumption | 3 | 1988 | 423 | 0.010 |
Why?
|
| Gamma Rays | 1 | 1979 | 241 | 0.010 |
Why?
|
| Cheek | 2 | 1988 | 57 | 0.010 |
Why?
|
| Diazepam | 1 | 1997 | 46 | 0.010 |
Why?
|
| Mesocricetus | 2 | 1988 | 119 | 0.010 |
Why?
|
| Ovary | 1 | 2001 | 701 | 0.010 |
Why?
|
| Capillaries | 2 | 1988 | 104 | 0.010 |
Why?
|
| Interferons | 1 | 1979 | 301 | 0.010 |
Why?
|
| Middle Aged | 3 | 2015 | 90460 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 1728 | 0.010 |
Why?
|
| Electromyography | 1 | 1997 | 234 | 0.010 |
Why?
|
| Lysine | 1 | 1979 | 428 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2001 | 1020 | 0.010 |
Why?
|
| Cricetinae | 2 | 1988 | 793 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 2 | 1988 | 189 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 31066 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 7958 | 0.010 |
Why?
|
| Haplorhini | 1 | 1994 | 156 | 0.010 |
Why?
|
| Biopsy | 1 | 2001 | 3544 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 22142 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 39831 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 2256 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1997 | 996 | 0.010 |
Why?
|
| Laos | 1 | 1989 | 6 | 0.010 |
Why?
|
| Rheology | 2 | 1980 | 47 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1990 | 264 | 0.010 |
Why?
|
| Zoonoses | 1 | 1989 | 54 | 0.010 |
Why?
|
| HIV Infections | 1 | 2001 | 2158 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 73517 | 0.010 |
Why?
|
| Vascular Resistance | 2 | 1980 | 215 | 0.000 |
Why?
|
| Erythrocyte Count | 1 | 1988 | 35 | 0.000 |
Why?
|
| Leg | 2 | 1980 | 216 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1988 | 127 | 0.000 |
Why?
|
| Antibodies, Protozoan | 1 | 1988 | 86 | 0.000 |
Why?
|
| Prostaglandins | 1 | 1987 | 84 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1987 | 211 | 0.000 |
Why?
|
| Autoanalysis | 1 | 1977 | 10 | 0.000 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1987 | 12 | 0.000 |
Why?
|
| Prostaglandins E | 1 | 1987 | 23 | 0.000 |
Why?
|
| Online Systems | 1 | 1977 | 26 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1987 | 149 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 1534 | 0.000 |
Why?
|
| Spinal Cord Diseases | 1 | 1987 | 90 | 0.000 |
Why?
|
| Endothelium | 1 | 1987 | 162 | 0.000 |
Why?
|
| Nervous System | 1 | 1987 | 183 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1988 | 738 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1987 | 340 | 0.000 |
Why?
|
| Quality Control | 1 | 1977 | 467 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1987 | 515 | 0.000 |
Why?
|
| Biomarkers, Tumor | 1 | 2001 | 10750 | 0.000 |
Why?
|
| Prevalence | 1 | 1990 | 3427 | 0.000 |
Why?
|
| Catecholamines | 1 | 1981 | 100 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1990 | 5001 | 0.000 |
Why?
|
| Body Temperature | 1 | 1981 | 165 | 0.000 |
Why?
|
| Doppler Effect | 1 | 1980 | 5 | 0.000 |
Why?
|
| Lactates | 1 | 1980 | 123 | 0.000 |
Why?
|
| Leg Injuries | 1 | 1980 | 31 | 0.000 |
Why?
|
| Iliac Artery | 1 | 1980 | 101 | 0.000 |
Why?
|
| Potassium | 1 | 1980 | 349 | 0.000 |
Why?
|
| Blood Flow Velocity | 1 | 1979 | 543 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1979 | 1943 | 0.000 |
Why?
|